drug
denosumab
Marketedupdated 3mo agoby $AMGN AMGEN INC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8all catalysts(1)
Trials studying denosumab
- phase3A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis
- phase2Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
- phase2Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
- phase2Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma
- phase4A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China
- phase2Romosozumab/Denosumab Study for Premenopausal IOP
- phase2A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
- phase4Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
News(1)
- Dr Silbermann on Clinical Trial Design Considerations in Multiple MyelomaRebecca Silbermann, MD, MMS, outlines key trial design considerations in multiple myeloma, including supportive care measures and end point selection.onclive · 3mo ago
Data sources
last refreshed 37m ago
Found something off?
comments(0)
5-min edit window · permanent after that